GrayMatters Health Overview
GrayMatters Health (GMH) develops digital self-neuromodulation therapeutics for mental disorders to help patients regain agency over their emotion regulation. GMH offers Prism, a noninvasive adjunct therapeutic that utilizes novel neuroscience-based and brain-mechanism-specific biomarkers. The company's first product candidate, Prism for post-traumatic stress disorder (PTSD), is undergoing clinical investigation in five sites across the United States and Israel, to demonstrate its efficacy and safety as an adjunct to standard PTSD treatments. Our first product, Prism for PTSD, was cleared by FDA in March 2023. The novel technology was developed by Professor Talma Hendler and her team at Tel Aviv Sourasky Medical Center and Tel Aviv University.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Israeli startup GrayMatters treats PTSD with avatars
Israeli company GrayMatters, which develops innovative treatments for post-traumatic stress disorder (PTSD), has received approval from the US FDA and Israels Ministry of Health to market its technology. The company uses AI software and an EEG headset device to read biomarker activity in the amygdala, the part of the brain which is overactive in people suffering from PTSD. The treatment is administered during 15 visits each lasting 30 minutes, in which the patients see avatars in front of them that they have to move. The company has raised $20 million to date and has begun initial sales in the US.
CustomersInvestmentPartners
Growth-Positive
GrayMatters Health Receives Investment from European Innovation Council (EIC) Fund
GrayMatters Health (GMH), a developer of digital self-neuromodulation therapies for mental disorders, has received an investment from the European Innovation Council (EIC) Fund. This follows a €2.5M grant awarded to GMH by the EIC in September 2022. The funds will be used for the continued development of GMHs flagship product, Prism for PTSD, a non-invasive digital therapy for post-traumatic stress disorder (PTSD), and for a large-scale study in the EU. The EIC Funds investment was advised by the European Investment Bank (EIB).
InvestmentExpand
GrayMatters Health Awarded €2.5M in Funding from European Innovation Council
growth-positive
GrayMatters Health Closes $10M Round A Funding and Partnership in Japan
GrayMatters Health (GMH), a developer of digital self-neuromodulation therapeutics for mental disorders, has raised $10 million in a Series A funding round. The round was led by Otsuka Medical Devices Co., Ltd. (OMD), and included participation from Joy Ventures, J-Ventures, J-Impact, Marius Nacht, and Joyance Ventures. GMH will use the funds to complete its clinical investigation, obtain regulatory clearance, and launch Prism for PTSD in the United States. Prism is a non-invasive adjunct digital therapeutic that uses machine learning technology to create an Electrical-Finger-Print (EFP) of brain-mechanism-specific biomarkers for the treatment of mental disorders.
Investment
growth-positive
McLean Hospital and GrayMatters Health Awarded a BIRD Foundation Grant to Develop a Digital Therapy for Major Depression Disorder with Anhedonia Symptoms
Digital therapeutics start-up GrayMatters Health and McLean Hospital have been awarded a grant by the BIRD Israel-U.S. Binational Industrial Research and Development Foundation. The grant will fund the development of a novel solution for the therapy of Major Depression Disorder (MDD) based on GrayMatters patented fMRI-to-EEG machine-learning platform, Prism. The treatment aims to help individuals with MDD who are unable to feel pleasure learn how to control and modulate their reward system. The project will also allow GrayMatters to expand its indications from PTSD to depression.
PartnersInvestment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $18.3M |
| Last funding | $2.1M |
| Stage | A |
| Rounds | 4 |
| Investors | 8 |
Team Members
4
Employees: 11-50
Web & Social Links
| Website | www.graymatters-health.com |
Locations
Derech HaAtsma'ut 82, Haifa, Israel
Photos & Videos
1 item(s)
